EudraVigilance information day

Date: 15/12/2017
Location: European Medicines Agency, London, UK
This EudraVigilance information day provides a forum to discuss the very initial experience of stakeholders with the new EudraVigilance system functionalities following its launch in November 2017, the use of the new ICH E2B(R3) standard, the simplified adverse reaction reporting and the data analysis outputs. The Information Day will also serve as a platform to experts to raise questions on the practical application of the recently revised GVP Modules VI and IX.

How useful was this page?

Add your rating